argenx SE (ARGX) stock
ARGXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$960.04−21.29 (-2.17%)
Close on Nov 13, 2026Market cap –P/E 49.1Yield –
argenx price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
argenx's price to sales ratio was 40.8× on Feb 28, 2023, against 360.4× a year earlier. Over the last 4 years it ranged from 29.9× to 436.4×, with a median of 200.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2023 | Feb 28, 2023 | 40.8× | −1.2 |
| 2022 | Dec 30, 2022 | 41.9× | −394.5 |
| 2021 | Dec 31, 2021 | 436.4× | +276.1 |
| 2020 | Dec 31, 2020 | 160.3× | −108.5 |
| 2019 | Dec 31, 2019 | 268.8× | – |
See a number that looks wrong?